Hypovitaminosis D in patients with neuroendocrine tumors undergoing SSA therapy

#3308

Introduction: Neuroendocrine tumors of the gastrointestinal tract are rare tumors representing a heterogeneous group of tumors. Somatostatin analogues are commonly used in the treatment of gastroeenteropancreatic neuroendocrine tumors.

Aim(s): The aim of the study was to determine the potential side effects of SSA treatment based on the hypothesis of impaired absorption of fat-soluble vitamins from the intestine.

Materials and methods: The set consisted of patients undergoing treatment with somatostatin analogues in an outpatient form. We evaluated data about disease duration, SSA treatment, and type of SSA preparation. Subsequently, patients underwent blood tests focused on vitamin D levels.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Nosakova L

Authors: Nosakova L, Bánovčin P, Uhrík P, Pindura M, Hyrdel R,

Keywords: neuroendocrine tumor, somatostatin analogues, hypovitaminosis D,